Åslaug Helland
Oncologist, Oslo University Hospital, Head of Research, Oslo Comprehensive Cancer Center, OUS, Professor University of Oslo, Norway
Åslaug Helland, MD PhD, is head of research in the OECI accredited Oslo Comprehensive Cancer Center (CCC). She works as an oncologist specialized in lung cancer, and leads several clinical studies in lung cancer, including both investigator initiated clinical studies and studies initiated by the pharmaceutical industry.
She is PI in the PCM clinical study IMPRESS-Norway, with 23 hospitals participating.
She is heading a research group at the Institute of Cancer Research. This group, Translational Research in Solid Tumours, with 18 members, works on biomarker and biological research in lung, mesothelioma and pancreatic cancer. Focus are studies involving biomarker work and biological mechanisms underlying response. Studies are done on both tumour material and on blood samples from patients included in clinical studies.
She has supervised 9 previous PhD-candidates , in addition to 10 current PhD-students. Helland is author of 136papers (clinical, translational, epigenetics, epidemiologic), with 5856 citations and h-index 40 (Researchgate Nov. 2020).
Helland is also board member of the patient organization (Lungekreftforeningen), in the Norwegian Oncology Society (NOF) and in the Norwegian Lung Cancer Group (NLCG).
